![Thomas Bures](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Bures
Comptroller/Controller/Auditor at
BRUKER CORPORATION
Net worth: 188 330 $ as of 31/05/2026
Profile
Thomas Bures is Chief Accounting Officer at Bruker Corp.
since 2025.
Formerly, Mr. Bures was Senior VP, Chief Financial & Accounting Officer at Pieris Pharmaceuticals, Inc. from 2021 to 2024, Vice President & Controller at Genocea Biosciences, Inc. from 2015 to 2017, Vice President & Assistant Controller at PAREXEL International Corp., and Chief Financial Officer at Palvella Therapeutics, Inc. Education includes an undergraduate degree from College of the Holy Cross (Massachusetts).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/02/2026 | 3,198 ( 0% ) | 188 330 $ | 31/05/2026 |
Thomas Bures active positions
| Companies | Position | Start |
|---|---|---|
| BRUKER CORPORATION | Comptroller/Controller/Auditor | 13/01/2025 |
Former positions of Thomas Bures
| Companies | Position | End |
|---|---|---|
| PIERIS PHARMACEUTICALS | Director of Finance/CFO | 13/12/2024 |
| GENOCEA BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 01/12/2017 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Training of Thomas Bures
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
31
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Bruker Corp.
 Bruker Corp. Medical SpecialtiesHealth Technology Manufactures analytical and medical instruments | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
- Stock Market
- Insiders
- Thomas Bures
